lethargy; fever of 99.06/ Very slight fever; disturbing barrel cough (sounded like a whopping cough); On 10Apr I tested positive for COVID; On 10Apr I tested positive for COVID; sore throat; headaches; abdominal distress; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Mar2021 as dose 1, single (Lot number: EN6205), in right arm, on 26Mar2021 as dose 2, single (Lot number: EP7534), in right arm and on 30Oct2021 as dose 3 (booster), single (Lot number: EW0167) at the age of 70 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "lifelong asthma" (unspecified if ongoing), notes: lifelong asthma; "thyroid disease" (unspecified if ongoing), notes: thyroid disease; "upper intestinal (celiac)" (unspecified if ongoing), notes: upper intestinal (celiac); "many foods (gluten, dairy, soy, chocolate, etc)" (unspecified if ongoing), notes: many foods (gluten, dairy, soy, chocolate, etc); "many foods (gluten, dairy, soy, chocolate, etc)" (unspecified if ongoing), notes: many foods (gluten, dairy, soy, chocolate, etc); "many foods (gluten, dairy, soy, chocolate, etc)" (unspecified if ongoing), notes: many foods (gluten, dairy, soy, chocolate, etc); "many foods (gluten, dairy, soy, chocolate, etc)" (unspecified if ongoing), notes: many foods (gluten, dairy, soy, chocolate, etc). Concomitant medication(s) included: EXCEDRINIL; OMEPRAZOLE. Past drug history included: Sulfa, reaction(s): "Known allergies: sulfa". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 10Apr2022, outcome "recovered" (26Apr2022) and all described as "On 10Apr I tested positive for COVID"; ABDOMINAL DISCOMFORT (non-serious) with onset 10Apr2022, outcome "recovering", described as "abdominal distress"; HEADACHE (non-serious) with onset 10Apr2022, outcome "recovering", described as "headaches"; OROPHARYNGEAL PAIN (non-serious) with onset 10Apr2022, outcome "recovering", described as "sore throat"; COUGH (non-serious) with onset 11Apr2022, outcome "recovering", described as "disturbing barrel cough (sounded like a whopping cough)"; PYREXIA (non-serious) with onset 20Apr2022, outcome "recovering", described as "fever of 99.06/ Very slight fever"; LETHARGY (non-serious) with onset 20Apr2022, outcome "recovering". The patient underwent the following laboratory tests and procedures: Body temperature: (20Apr2022) 99.06; SARS-CoV-2 test: (10Apr2022) Positive; (20Apr2022) very faint COVID; (23Apr2022) positive, notes: home test strong positive; (26Apr2022) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19, oropharyngeal pain, headache, abdominal discomfort, cough, lethargy, pyrexia. Clinical course: Anti viral were used for COVID-19 Treatment from 13Apr2022 to 17Apr2022. Other medication in two weeks were product-Excedrin and Omeprazole from Bayer and generic respectively. Post-Paxlovid rebound. On 10Apr she tested positive for COVID (sore throat, headaches, abdominal distress, 11Apr evening developed a disturbing barrel cough (sounded like a whopping cough) 13Apr started Paxlovid and started feeling much better (bitter taste was amusing then annoying then aggravating) 17Apr finished Paxlovid, 20Apr started feeling ill with fever of 99.06 and a very faint COVID line on a home test, continuing COVID symptoms (headache, very slight fever, raspy throat, lethargy, abdominal distress) 23Apr COVID home test strong positive. 26Apr negative COVID test.  No follow-up attempts are possible. No further information is expected.